XML 39 R31.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Information (Tables)
 9 Months Ended
Sep. 30, 2012
Segment Reporting [Abstract]  
Schedule of Segment Information
Three Months
Ended September 30,
Agriculture1
Electronics &
Communications
Industrial Biosciences
Nutrition & Health
Performance
Chemicals
Performance
Materials
Safety &
Protection
Pharm-aceuticals
Other
Total
2012
 

 
 

 
 
 
 
 
 

 
 

 
 

 
 

 
 

 
 

Segment sales
$
1,423

 
$
607

 
$
292

 
$
876

 
$
1,732

 
$
1,614

 
$
934

 
$
—

 
$
2

 
$
7,480

Less: Transfers
—

 
4

 
3

 
—

 
56

 
24

 
3

 
—

 
—

 
90

Net sales
1,423

 
603

 
289

 
876

 
1,676

 
1,590

 
931

 
—

 
2

 
7,390

PTOI
(213
)
2,3 
(117
)
3,4 
39

3 
74

3 
369

3 
205

3,4 
48

3 
10

 
(59
)
 
356

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2011
 

 
 

 
 
 
 
 
 

 
 

 
 

 
 

 
 

 
 

Segment sales
$
1,368

 
$
841

 
$
293

 
$
844

 
$
2,142

 
$
1,745

 
$
1,001

 
$
—

 
$
2

 
$
8,236

Less: Transfers
1

 
4

 
4

 
—

 
58

 
27

 
4

 
—

 
—

 
98

Net sales
1,367

 
837

 
289

 
844

 
2,084

 
1,718

 
997

 
—

 
2

 
8,138

PTOI
(194
)
2,5 
99

 
(27
)
6 
(34
)
6 
593

 
231

 
118

 
70

 
(78
)
6 
778


Nine Months
Ended September 30,
Agriculture1
Electronics &
Communications
Industrial Biosciences
Nutrition & Health
Performance
Chemicals
Performance
Materials
Safety &
Protection
Pharm-aceuticals
Other
Total
2012
 

 
 

 
 
 
 
 
 

 
 

 
 

 
 

 
 

 
 

Segment sales
$
8,891

 
$
2,079

 
$
880

 
$
2,569

 
$
5,600

 
$
4,913

 
$
2,861

 
$
—

 
$
4

 
$
27,797

Less: Transfers
4

 
13

 
8

 
—

 
202

 
74

 
9

 
—

 
—

 
310

Net sales
8,887

 
2,066

 
872

 
2,569

 
5,398

 
4,839

 
2,852

 
—

 
4

 
27,487

PTOI
1,712

2,3 
113

3,4,7 
124

3 
269

3 
1,419

3 
762

3,4 
275

3 
53

 
(325
)
8 
4,402

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2011
 

 
 

 
 
 
 
 
 

 
 

 
 

 
 

 
 

 
 

Segment sales
$
7,869

 
$
2,543

 
$
416

 
$
1,654

 
$
5,934

 
$
5,197

 
$
2,991

 
$
—

 
$
39

 
$
26,643

Less: Transfers
1

 
14

 
5

 
—

 
194

 
81

 
10

 
—

 
—

 
305

Net sales
7,868

 
2,529

 
411

 
1,654

 
5,740

 
5,116

 
2,981

 
—

 
39

 
26,338

PTOI
1,743

2,5 
313

 
(34
)
6,9 
(4
)
6,9 
1,490

 
773

 
406

 
200

 
(179
)
6 
4,708


1 
As of September 30, 2012, Agriculture net assets were $8,306, an increase of $3,541 from $4,765 at December 31, 2011. The increase was primarily due to higher trade receivables due to normal seasonality in the sales and cash collections cycle.
2 
Included charges of $(125) and $(440) during the three and nine months ended September 30, 2012, respectively, and a $(75) charge during the three and nine months ended September 30, 2011, recorded in cost of goods sold and other operating charges associated with the company's process to fairly resolve claims associated with the use of Imprelis®. See Note 9 for additional information.
3 
Included a $(93) restructuring charge impacting the following segments: Agriculture - $(3), Electronics & Communications - $(7), Industrial Biosciences - $(3), Nutrition & Health - $(13), Performance Chemicals - $(3), Performance Materials - $(9), and Safety & Protection - $(55).
4 
Included a $(242) impairment charge recorded in employee separation/asset related charges, net related to asset groupings, which impacted the segments as follows: Electronics & Communications - $(150) and Performance Materials - $(92). See Note 3 for additional information.
5 
Included a $(50) charge recorded in research and development expense in connection with a milestone payment associated with a Pioneer licensing agreement. Since this milestone was reached before regulatory approval was secured by Pioneer, it was charged to research and development expense.
6 
Included charges related to the Danisco acquisition of $(168). These charges included $(132) recorded in cost of goods sold and other operating charges for transaction related costs and the fair value step-up of inventories that were acquired from Danisco and sold in the third quarter 2011. These charges also included a $(36) restructuring charge recorded in employee separation / asset related charges, net related to severance and related benefit costs. These charges impacted the segments as follows: Industrial Biosciences - $(61), Nutrition & Health - $(89) and Other - $(18).
7 
Included a $122 gain recorded in other (loss) income, net related to the sale of the company's interest in an equity method investment.
8 
Included a $(137) charge recorded in cost of goods sold and other operating charges primarily related to the company's settlement of litigation with INVISTA. See Note 9 for additional information.
9 
Included a $(50) charge recorded in cost of goods sold and other operating charges for transaction related costs and the fair value step-up of inventories that were acquired from Danisco and sold in the second quarter 2011, which impacted the segments as follows: Industrial Biosciences - $(17) and Nutrition & Health - $(33).
Reconciliation to Consolidated Income Statements
 
Three Months Ended
 September 30,
Nine Months Ended
 September 30,
 
2012
2011
2012
2011
Total segment PTOI
$
356

$
778

$
4,402

$
4,708

Net exchange (losses) gains, including affiliates
(130
)
6

(161
)
(132
)
Corporate expenses and net interest
(400
)
(333
)
(1,110
)
(1,098
)
(Loss) income from continuing operations before income taxes
$
(174
)
$
451

$
3,131

$
3,478